Medical News

RSS

In pregnant women, DVT more likely to occur on left side

Deep vein thrombosis (DVT) in pregnant patients is more likely to occur on the left side, and in particular in the left leg, write the authors of a Review article in CMAJ (Canadian Medical Association Journal) http://www.cmaj.ca/embargo/cmaj091692.pdf.

30 Mar 2010

Senesco Technologies signs definitive agreements with institutional and accredited investors

Senesco Technologies, Inc. has, on March 26, 2010, entered into definitive agreements with institutional and accredited investors for a private placement of up to 11,497 shares of Convertible Preferred Stock of the Company and Warrants to purchase up to 35,928,125 shares of Common Stock for a gross purchase price of approximately $11,497,000.

30 Mar 2010

Dicerna Pharmaceuticals, Ipsen announce collaboration in DsiRNA research and peptide engineering

Dicerna Pharmaceuticals, Inc., (Dicerna) a second generation RNA interference (RNAi) company, and Ipsen, a global biotechnology specialty care group, announced today that the two companies have entered into an exclusive research collaboration agreement to leverage their expertise in Dicer Substrate siRNA (DsiRNA) research and peptide engineering. The companies will develop novel conjugates of Dicerna's DsiRNA molecules and Ipsen's peptide targeting vectors in the therapeutic areas of oncology and endocrinology.

30 Mar 2010

Vertical living kids

A University of Melbourne Associate Professor Carolyn Whitzman has recently concluded a study called “Vertical living kids” which proves that children living in high rises are not as independent as those living in the suburbs. They are far more dependent on parental supervision when planning outings and excursions.

30 Mar 2010

Tomato genes could be used as future treatment in gene therapy: Study

Tomato genes could be used as a future treatment in gene therapy, according to new research results from Lund University.

30 Mar 2010

Kylie Minogue supports breast cancer initiative

Australian singer Kylie Minogue is part of this year’s Fashion Targets Breast Cancer campaign. Kylie is a cancer survivor who was diagnosed with the disease in May 2005. She had to cancel her Showgirl world tour’s Australian leg because of that.

30 Mar 2010

Research challenges current thinking about TB bacterium

Two new tuberculosis studies by UT Southwestern Medical Center researchers provide good news and bad news about the bacterium that infects nearly a third of the world's population and a disease that kills nearly 2 million people each year.

30 Mar 2010

Alpha Pro Tech changes distribution strategy for disposable protective apparel

Alpha Pro Tech, Ltd. a leading manufacturer of products designed to protect people, products and environments, including disposable protective apparel and building products, today announced a strategic change in the Company's disposable protective apparel distribution strategy.

30 Mar 2010

EPA's Action Plan on BPA: ACC issues statement

The Environmental Protection Agency (EPA) today released an Action Plan on bisphenol A (BPA).

30 Mar 2010

Vcorp Services announces strategic alliance with PRTechConnect

Vcorp Services LLC, a leader in specialized state corporate filing services for small companies, and PRTechConnect, a flat-fee PR service for startups, today announced a strategic alliance to spotlight critical services available for small businesses at affordable prices.

30 Mar 2010

Acupuncture can help calm anxiety related to dental treatment

Acupuncture can calm highly anxious dental patients and ensure that they can be given the treatment they need, suggests a small study published in Acupuncture in Medicine.

30 Mar 2010

Woman sentenced in Michigan Medicare fraud case; Medicaid fraud alleged in NY dental clinics

Profits came quickly: Over one year, Daisy Martinez ripped off Medicare for $10.7 million at three clinics, and her daughter got $649,000 in just four months as they billed the government for sham drug treatments while luring desperate people off the street with cash, food and painkillers.

30 Mar 2010

Westaim completes acquisition of JEVCO

The Westaim Corporation today announced that it has completed the acquisition of all of the shares of JEVCO Insurance Company from Kingsway Financial Services Inc. (KFS) pursuant to the terms of the purchase agreement dated as of January 25, 2010, as amended between Westaim and KFS.

30 Mar 2010

Potential new target for treating HCV infection

A team of scientists including University of Utah researchers has discovered that binding of a potent inhibitor of the hepatitis C virus to the genetic material of the virus causes a major conformational change that may adversely affect the ability of the virus to replicate.

30 Mar 2010

Royal Philips Electronics introduces InnerCool RTx Endovascular System

Royal Philips Electronics announced today its launch of the Philips InnerCool RTx Endovascular System for cooling and warming, which provides advanced whole body temperature modulation therapy in a closed-loop system from the inside out. The InnerCool RTx is a high-performance system that can rapidly raise and lower the body temperature of certain non-paralyzed, awake patients of all sizes in the intensive care setting.

From Philips Healthcare 30 Mar 2010

Polls show Dems face uphill climb in selling health votes to electorate

USA Today On Politics Blog: A USA Today/Gallup Poll that will be published in Tuesday's USA Today "shows an uphill selling job ahead for President Obama and congressional Democrats to convince most Americans that the health care overhaul passed last week will help them and their families. In the poll, 50% call passage of the bill 'a bad thing' and 47% say it was 'a good thing.'" These findings are less favorable than a one-day poll taken a week earlier-- a day after the health overhaul measure was approved by the House of Representatives.

30 Mar 2010

Intellikine, Tragara Pharmaceuticals awarded $1M each for developing new multiple myeloma therapies

The Multiple Myeloma Research Foundation (MMRF) today announced that two San Diego area biotech firms, Intellikine and Tragara Pharmaceuticals, Inc. will receive funding via its MMRF Biotech Investment Award program. The MMRF Biotech Investment Awards represent a multi-year research grant commitment to fund the early-stage drug development of novel compounds and approaches that show potential in treating multiple myeloma. Based on the companies' achievement of clearly defined milestones, the MMRF will commit a total of $1,000,000 to each company by the end of 2011.

30 Mar 2010

Adoption of healthcare IT is on steady incline in small physician practice: NaviNet survey

Adoption of healthcare IT is on a steady incline in the small physician practice, reveals a survey by NaviNet, America's largest real-time healthcare communications network. In early March 2010, NaviNet conducted a survey of IT and electronic medical record adoption trends in small practices and compared results to a similar survey the company issued to small practices in August 2009.

30 Mar 2010

Enrollment complete in Paradigm Spine's comparative study of coflex interlaminar technology

Paradigm Spine, LLC, a developer of innovative non-fusion and fusion spinal implant solutions, announced today that it has completed patient enrollment in an Investigational Device Exemption pivotal clinical study comparing the coflex® interlaminar technology to instrumented posterolateral fusion in the surgical treatment of spinal stenosis.

30 Mar 2010

Devereux Florida's Viera Campus secures $100,000 in federal funds

Devereux Florida's Viera Campus has secured $100,000 in federal funds to renovate a 21,000 square foot facility that serves over 500 children each year who are in need of improved physical, social and emotional health.

30 Mar 2010